Growth Metrics

Elutia (ELUT) Operating Leases (2022 - 2026)

Elutia recorded quarterly Operating Leases of $3.7 million in Q1 2026, up 3.01% quarter-over-quarter from $3.6 million in Q4 2025, and up 1058.31% year-over-year from $319000.0 in Q1 2025.

Elutia's Operating Leases history runs 5 years deep, the most recent figure standing at $3.7 million for Q1 2026.

  • In Q1 2026, Operating Leases rose 1058.31% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 1058.31% YoY), while the FY2025 annual figure was $3.6 million, up 22318.75% from the prior year.
  • Operating Leases came in at $3.7 million for Q1 2026 at Elutia, up from $3.6 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $3.7 million in Q1 2026 to a low of $16000.0 in Q4 2024.
  • A 5-year average of $1.7 million and a median of $956000.0 in 2022 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases jumped 22318.75% in 2025 and soared 1058.31% in 2026, its largest moves.
  • Elutia's Operating Leases stood at $956000.0 in 2022, then dropped by 25.63% to $711000.0 in 2023, then tumbled by 97.75% to $16000.0 in 2024, then surged by 22318.75% to $3.6 million in 2025, then gained by 3.01% to $3.7 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $3.7 million, $3.6 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Elutia 45.79 Mn 17.31 Mn 1.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.70 Mn
Dec 31, 2025 3.59 Mn
Sep 30, 2025 2.81 Mn
Jun 30, 2025 2.72 Mn
Mar 31, 2025 319,000.00
Dec 31, 2024 16,000.00
Jun 30, 2023 711,000.00
Mar 31, 2023 835,000.00
Dec 31, 2022 956,000.00